相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Socio-economic inequality of utilization of cancer testing in Europe: A cross-sectional study
H. Bozhar et al.
PREVENTIVE MEDICINE REPORTS (2022)
Impact of the Mobile Game FightHPV on Cervical Cancer Screening Attendance: Retrospective Cohort Study
Madleen Orumaa et al.
JMIR SERIOUS GAMES (2022)
2020 list of human papillomavirus assays suitable for primary cervical cancer screening
Marc Arbyn et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Human Papillomavirus Detection by Whole-Genome Next-Generation Sequencing: Importance of Validation and Quality Assurance Procedures
Laila Sara Arroyo Muhr et al.
VIRUSES-BASEL (2021)
The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis
J. Norenhag et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2020)
Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans
P. J. Maver et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
Marc Arbyn et al.
LANCET GLOBAL HEALTH (2020)
Perspectives of non-attenders for cervical cancer screening in Norway: a qualitative focus group study
Gunvor Aasbo et al.
BMJ OPEN (2019)
Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines
Kine Pedersen et al.
EUROPEAN JOURNAL OF CANCER (2018)
Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
Jane J. Kim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
Jane J. Kim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Advancing the evaluation of cervical cancer screening: development and application of a longitudinal adherence metric
Kine Pedersen et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2017)
Barriers to cervical cancer screening faced by immigrants: a registry-based study of 1.4 million women in Norway
Maarit K. Leinonen et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2017)
Personal and provider level factors influence participation to cervical cancer screening: A retrospective register-based study of 1.3 million women in Norway
Maarit K. Leinonen et al.
PREVENTIVE MEDICINE (2017)
A systematic review and meta-analysis of studies evaluating the performance of point-of-care tests for human papillomavirus screening
Helen Kelly et al.
SEXUALLY TRANSMITTED INFECTIONS (2017)
Biomarkers for Cervical Cancer Prevention Programs
Nicolas Wentzensen et al.
Journal of Lower Genital Tract Disease (2016)
A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
E. A. Joura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Comparing Cervical Cytology and Histology Among Human Papillomavirus-Vaccinated and -Unvaccinated Women in an Academic Colposcopy Clinic
Benjamin J. Dorton et al.
OBSTETRICS AND GYNECOLOGY (2015)
European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination
Lawrence von Karsa et al.
PAPILLOMAVIRUS RESEARCH (2015)
50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence
S. Vaccarella et al.
BRITISH JOURNAL OF CANCER (2014)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco et al.
LANCET (2014)
Cervical screening participation and risk among Swedish-born and immigrant women in Sweden
Fatima Azerkan et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening
Dorien C. Rijkaart et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer
Peng Guan et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Variable Risk of Cervical Precancer and Cancer After a Human Papillomavirus-Positive Test
Philip E. Castle et al.
OBSTETRICS AND GYNECOLOGY (2011)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose et al.
LANCET ONCOLOGY (2010)
Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme
Ahti Anttila et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
Joalim Dillner et al.
BRITISH MEDICAL JOURNAL (2008)
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
N. W. J. Bulkmans et al.
LANCET (2007)
Human papillomavirus and papanicolaou tests to screen for cervical cancer
Pontus Naucler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The predicted effect of changes in cervical screening practice in the UK: results from a modelling study
K Canfell et al.
BRITISH JOURNAL OF CANCER (2004)
分享论文
